To probe the association between different clinicopathological parameters and KMO expression in patients with breast cancer, the Breast Cancer Gene-Expression Miner (bc-GenExMiner), which evaluated the in vivo prognostic role of KMO in breast cancer, was used [27]. This evidence concerns the gene KMO and breast cancer.